Cargando…
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease-2019 (COVID-19), interacts with the host cell receptor angiotensin-converting enzyme 2 (hACE2) via its spike 1 protein during infection. After the virus sequence was published, we identified two potent ant...
Autores principales: | Gu, Chunyin, Cao, Xiaodan, Wang, Zongda, Hu, Xue, Yao, Yanfeng, Zhou, Yiwu, Liu, Peipei, Liu, Xiaowu, Gao, Ge, Hu, Xiao, Zhang, Yecheng, Chen, Zhen, Gao, Li, Peng, Yun, Jia, Fangfang, Shan, Chao, Yu, Li, Liu, Kunpeng, Li, Nan, Guo, Weiwei, Jiang, Guoping, Min, Juan, Zhang, Jianjian, Yang, Lu, Shi, Meng, Hou, Tianquan, Li, Yanan, Liang, Weichen, Lu, Guoqiao, Yang, Congyi, Wang, Yuting, Xia, Kaiwen, Xiao, Zheng, Xue, Jianhua, Huang, Xueyi, Chen, Xin, Ma, Haixia, Song, Donglin, Pan, Zhongzong, Wang, Xueping, Guo, Haibing, Liang, Hong, Yuan, Zhiming, Guan, Wuxiang, Deng, Su-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189090/ https://www.ncbi.nlm.nih.gov/pubmed/34097570 http://dx.doi.org/10.1080/19420862.2021.1930636 |
Ejemplares similares
-
The SARS-CoV-2 B.1.351 Variant Can Transmit in Rats But Not in Mice
por: Zhang, Cheng, et al.
Publicado: (2022) -
An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases
por: Liu, Peipei, et al.
Publicado: (2020) -
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021) -
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice
por: Martinez, David R., et al.
Publicado: (2021) -
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
por: Du, Shuo, et al.
Publicado: (2021)